A Resource for Healthcare and Social Services Professionals
July 25, 2024
12:00 pm–1:00 pm ET
This training provides healthcare teams with information on available injectable buprenorphine formulations for the treatment of opioid use disorder and how to implement them into clinical practice.
Via Zoom
This training provides healthcare teams with information on available injectable buprenorphine formulations for the treatment of opioid use disorder and how to implement them into clinical practice.
Topics include the pharmacology and side effects of injectable buprenorphine formulations, storage, administration and patient selection processes, dosage, initiation and maintenance for patients using weekly and monthly injectable doses, and the workflows and administrative tasks involved in implementing injectable buprenorphine in healthcare settings.
NOTE: This training is 60 minutes long. There will be an optional 30-minute Q&A session following the training, which will not count for credit.
Physicians, advanced practice providers, nurses, social workers, recovery coaches, and all other healthcare professionals treating addiction are welcome and encouraged to attend.
Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
REQUIREMENTS for credit
Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.
Joint Accreditation Statement for CME, Nursing, Social Work, and Psychology
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Nursing Contact Hours: 1.00 contact hours, of which 1.00 are eligible for pharmacology credit.
Social Work
As a Jointly Accredited Organization, Boston University Chobanian & Avedisian School of Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.00 general continuing education credits.
American Psychological Association (APA) CE Designation Statement:
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
New York State Psychology Credit:
Boston University Chobanian & Avedisian School of Medicine Barry M. Manuel Center for Continuing Education is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0181. Note: NYS psychologists must attend all sessions for credit. Partial credit is not allowed.
The Department’s approval of a provider of continuing education does not constitute the Department’s endorsement of the content, positions or practices that may be addressed in any specific continuing education course offered by the approved provider
LMHC
BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 1.00 contact hours will be offered to participants who attend the training and complete the evaluation.
LADC/CADC & Recovery Coach
Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS) to award LADC/CADC and Recovery Coaches who complete this trainings 1.00 continuing education credits.
Disclaimer
Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations.
THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTHCARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.